Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19506159

J. Clin. Oncol. 2009 Aug 10 27 23 3861-7

Download in:

View as

General Info

PMID
19506159